Literature DB >> 28285357

Alternative outcomes of pathogenic complex somatic structural variations in the genomes of NF1 and NF2 patients.

Meng-Chang Hsiao1, Arkadiusz Piotrowski1,2, Andrzej Brunon Poplawski1, Tom Callens1, Chuanhua Fu1, Ludwine Messiaen3.   

Abstract

Multiplex ligation-dependent probe amplification (MLPA) has been widely used to identify copy-number variations (CNVs), but MLPA's sensitivity and specificity in mosaic CNV detection are largely unknown. Here, we present two mosaic deletions identified by MLPA as NF1 deletion of exons 17-21 and NF2 deletion of exons 9-10. Through cDNA analysis, genomic breakpoint-spanning PCR and Sanger sequencing, we found however both NF1 and NF2 deletions are each composed of two consecutive deletions, which cannot be differentiated by MLPA. Importantly, these consecutive deletions are most likely originating from a single genomic rearrangement and have been preserved independently in different populations of cells.

Entities:  

Keywords:  Deletion; MLPA; Mosaic rearrangement mechanism; NF1; NF2

Mesh:

Year:  2017        PMID: 28285357     DOI: 10.1007/s10048-017-0512-x

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  24 in total

1.  Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females.

Authors:  Ken Inoue; Hitoshi Osaka; Virginia C Thurston; Joe T R Clarke; Akira Yoneyama; Lisa Rosenbarker; Thomas D Bird; M E Hodes; Lisa G Shaffer; James R Lupski
Journal:  Am J Hum Genet       Date:  2002-09-20       Impact factor: 11.025

2.  Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1).

Authors:  Ludwine Messiaen; Julia Vogt; Kathrin Bengesser; Chuanhua Fu; Fady Mikhail; Eduard Serra; Carles Garcia-Linares; David N Cooper; Conxi Lazaro; Hildegard Kehrer-Sawatzki
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

Review 3.  The mechanism of human nonhomologous DNA end joining.

Authors:  Michael R Lieber
Journal:  J Biol Chem       Date:  2007-11-12       Impact factor: 5.157

4.  Large intragenic deletions of the NF2 gene: breakpoints and associated phenotypes.

Authors:  Benjamin Abo-Dalo; Kerstin Kutsche; Victor Mautner; Lan Kluwe
Journal:  Genes Chromosomes Cancer       Date:  2010-02       Impact factor: 5.006

5.  Palindrome-mediated and replication-dependent pathogenic structural rearrangements within the NF1 gene.

Authors:  Meng-Chang Hsiao; Arkadiusz Piotrowski; John Alexander; Tom Callens; Chuanhua Fu; Fady M Mikhail; Kathleen B M Claes; Ludwine Messiaen
Journal:  Hum Mutat       Date:  2014-05-21       Impact factor: 4.878

6.  Identification of recurrent type-2 NF1 microdeletions reveals a mitotic nonallelic homologous recombination hotspot underlying a human genomic disorder.

Authors:  Julia Vogt; Tanja Mussotter; Kathrin Bengesser; Kathleen Claes; Josef Högel; Nadia Chuzhanova; Chuanhua Fu; Jenneke van den Ende; Victor-Felix Mautner; David N Cooper; Ludwine Messiaen; Hildegard Kehrer-Sawatzki
Journal:  Hum Mutat       Date:  2012-08-20       Impact factor: 4.878

7.  Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought.

Authors:  D Gareth R Evans; Anthony Moran; Andrew King; S Saeed; Nihal Gurusinghe; Richard Ramsden
Journal:  Otol Neurotol       Date:  2005-01       Impact factor: 2.311

8.  Meta-analysis of gross insertions causing human genetic disease: novel mutational mechanisms and the role of replication slippage.

Authors:  Jian-Min Chen; Nadia Chuzhanova; Peter D Stenson; Claude Férec; David N Cooper
Journal:  Hum Mutat       Date:  2005-02       Impact factor: 4.878

Review 9.  Somatic mosaicism: implications for disease and transmission genetics.

Authors:  Ian M Campbell; Chad A Shaw; Pawel Stankiewicz; James R Lupski
Journal:  Trends Genet       Date:  2015-04-21       Impact factor: 11.639

10.  The NF1 gene contains hotspots for L1 endonuclease-dependent de novo insertion.

Authors:  Katharina Wimmer; Tom Callens; Annekatrin Wernstedt; Ludwine Messiaen
Journal:  PLoS Genet       Date:  2011-11-17       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.